SULSA INDUSTRY SPONSORS
Meet our SULSA Industry Sponsors who work closely with SULSA to ensure better collaboration across universities and industry to meet the challenges in innovation and skills demand.
LifeArc
LifeArc is a self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections. They aim to deliver this by conducting and funding pioneering research and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments.
LifeArc have been doing this for more than 25 years and their work has resulted in five licensed medicines, Keytruda®(cancer), Leqembi® (Alzheimer’s disease), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) and Entyvio® (Crohn’s disease). LifeArc’s vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster.
RoukenBio
RoukenBio (formerly Antibody Analytics) are inspired by deconstructing the relative contributions of primary immune cells to disease pathology. Their goal is to provide physiologically relevant, in vitro models, that facilitate the mechanistic investigation of biologics and novel therapeutic approaches. With translational immunology platforms, cell line engineering services, biophysical characterisation (SPR), effector function packages and bioassay development capabilities, they can support biopharmaceutical companies seeking to overcome substantial scientific challenges from the very earliest stages of the drug discovery journey.
RoukenBio are experienced in characterising therapeutics that modulate the immune response. With a strong focus on targeted therapeutics, these include monoclonal antibodies, immune cell engagers, antibody drug conjugates, engineered cell therapies, oncolytic viruses, multi-functional biologics and novel platform technologies.
Charles River
Charles River are dedicated to helping their clients accelerate research and drug development—because every moment matters. Their essential products and services empower pharmaceutical, biotech, government, and academic teams to turn possibilities into breakthroughs. From discovery to early development and safe manufacturing, they provide the solutions needed to bring new therapies to patients faster.
What once started as a one-man laboratory in Boston in 1947, overlooking the Charles River, has evolved into a leading global strategic partner providing products and services to help expedite the discovery, early-stage development, and safe manufacture of novel drugs and therapeutics.
From their humble beginnings they have evolved into a global company operating over 130 facilities in 20 countries and are proud of their track record of having worked on over 805 of the novel FDA approved drugs over the last five years.
AliveDX
AliveDx empower diagnostic insights, transform patient care, and innovate for life. With 30+ years in in-vitro diagnostics, they advance global diagnostics in autoimmune, allergy, and beyond.
Their Alba, MosaiQ, and LumiQ brands generate both economic and clinical value by simplifying workflows and delivering fast, accurate results that enhance clinical decision-making.
